Except as expressly authorized by state law, ORS § 459A.200 to 459A.266 supersede and preempt any ordinance or other regulation enacted before, on or after September 29, 2019, by the governing body of a city, county or other political subdivision of this state that establishes or requires a program for the collection, by or on behalf of covered manufacturers, of:

Terms Used In Oregon Statutes 459A.260

  • City: includes any incorporated village or town. See Oregon Statutes 174.100
  • Oversight: Committee review of the activities of a Federal agency or program.

(1) Biologics;

(2) Covered drugs;

(3) Drugs for which a covered manufacturer administers a drug take-back program as part of a risk evaluation and mitigation strategy under the oversight of the federal Food and Drug Administration;

(4) Drugs that are used for animal medicines, including but not limited to parasiticide drugs for animals;

(5) Drugs administered in a clinical setting; or

(6) Dialysis concentrates and solutions used for kidney dialysis in a patient’s home. [2019 c.659 § 21]

 

See note under 459A.200.